Aptamin® C320 is another Aptamin that Nexmos developed for food & beverage ingredient, which is notified that a safe ingredient by FDA GRAS, October 2020. A use of Aptamin for food & beverage has been reviewed by FDA, and the result describes that there is no issue to use the DNA aptamer as a safety food ingredient. C320 supports human body keep cells healthy and safety via all functional abilities: actively and stably antioxidants delivery and effectively ROS removal.
Nexmos is a biotechnology company that developed World’s first DNA antioxidants meta-platform, Aptamin™. Aptamin™ is used in therapeutics, personal care solutions, and the food and beverage industries. The efficacy is unveiled by trial results.
UL hat diese Informationen vom Hersteller des Produktes übernommen. UL unternimmt umfangreiche Maßnahmen, um die Richtigkeit dieser Informationen sicherzustellen. Dennoch übernimmt UL keinerlei Verantwortung für diese Angaben und rät, nach der Materialauswahl die Angaben mit dem Hersteller direkt zu verifizieren.
Nexmos Co., Ltd. stellt seine Produktinformationen in den unten aufgezeigten Regionen zur Verfügung:
Sind Sie ein Händler und haben Interesse hier aufgeführt zu werden? Dann nehmen Sie Kontaktmit uns auf!
Lists combine the ease of Bookmarks with the versatility of Tags. Instead of one collection of bookmarked items, create as many collections, called "Lists," as you need.
Find the link to your List page in the user menu.
All Tags have been converted to separate Lists, and your bookmarked items have been saved to a "Bookmarks" List.
When you click the Add to List button, a dropdown of your existing Lists appears. Click the List name to which you want to add this product or formula.
You can also create a new List. Simply click "Create a New List" and enter a name.
When you define a new List, the current item is automatically added to it. You can add a product or formula to as many Lists as you need.
Easily see which Lists this item appears in, and quickly go to that List from the links that appear on the page.
